Authors:
Van De Donk, N
De Weerdt, O
Eurelings, M
Bloem, A
Lokhorst, H
Citation: N. Van De Donk et al., Malignant transformation of monoclonal gammopathy of undetermined significance: Cumulative incidence and prognostic factors, LEUK LYMPH, 42(4), 2001, pp. 609-618
Authors:
Eurelings, M
Notermans, NC
Van de Donk, NWCJ
Lokhorst, HM
Citation: M. Eurelings et al., Risk factors for hematological malignancy in polyneuropathy associated with monoclonal gammopathy, MUSCLE NERV, 24(10), 2001, pp. 1295-1302
Authors:
Eurelings, M
Notermans, NC
Franssen, H
van Es, HW
Ramos, LMP
Wokke, JHJ
van den Berg, LH
Citation: M. Eurelings et al., MRI of the brachial plexus in polyneuropathy associated with monoclonal gammopathy, MUSCLE NERV, 24(10), 2001, pp. 1312-1318
Authors:
Eurelings, M
Ang, CW
Notermans, NC
Van Doorn, PA
Jacobs, BC
Van den Berg, LH
Citation: M. Eurelings et al., Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy, NEUROLOGY, 57(10), 2001, pp. 1909-1912
Authors:
Eurelings, M
Moons, KGM
Notermans, NC
Sasker, LD
De Jager, AEJ
Wintzen, AR
Wokke, JHJ
Van den Berg, LH
Citation: M. Eurelings et al., Neuropathy and IgM M-proteins - Prognostic value of antibodies to MAG, SGPG, and sulfatide, NEUROLOGY, 56(2), 2001, pp. 228-233
Authors:
Notermans, NC
Franssen, H
Eurelings, M
Van der Graaf, Y
Wokke, JHJ
Citation: Nc. Notermans et al., Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy, MUSCLE NERV, 23(1), 2000, pp. 73-79